october, 2018



Event Details

Our meeting space is being provided by DeviceTalks 2018

Westin Boston Waterfront | 425 Summer St | Boston, MA 02210

For Driving and Parking Information, click here.

Program Description:

Your firm has revenues and a level of market acceptance and success. But the firm cannot grow to its full potential without significantly more capital. Your board and senior leadership team must decide whether to raise more capital with a new investment round, do an IPO, or look for a buyer for the company.

CEOs from different segments of the med tech and pharma space who have made these hard decisions will share their experiences. The interests of the founders and current investors must be considered. Control of the company will change.

  • How do the alternative financing paths change the risks and potential for achieving the company\’s potential value?
  • What is the market for raising funds or M&A, where will they be in 2 – 3 years?
  • What will be the role of the current management team and board under the different scenarios?

You will learn how our panel considered these factors and others when they had to decide which path to take for their company. And how did their decisions work out?

Keynote Speaker:

Walter Beinecke, Partner, Board Member, Member of Investment Committee, Brook Venture Partners

Walter is passionate about investing, supporting and partnering with management teams at expansion stage companies.

Special Introduction and Panel Moderated by:

Rick Williams, Managing Director, Williams Advisory Partners

Rick is a CEO and board advisor. Nationally published thought leader on preparing to raise capital, overcoming barriers to growth and preparing for the sale of the company.


Adam Gridley, President & CEO of Histogenics Corporation

Adam has over 20 years of transactional and operational experience in venture capital backed and public medical device, and pharmaceutical companies.

Peter Savas, CEO & Chairman, LikeMinds

Peter is a serial entrepreneur, strategic planner, value-added investor, executive chairman, director & advisor.

Come join this timely, lively, keynote presentation and blue-ribbon panel discussion. Ask questions and contribute your insights during the audience interactive segment.

Who should attend?

CEOs, board members, investors, and other senior leaders who want a better understanding of how to make important decisions at strategic inflection points for the company.


(Tuesday) 7:30 am - 10:00 am